Innovation in Healthcare
vivoMEDICA
is focussed on the development of
technologies and devices for the US and European healthcare markets.
The Company combines applied research capabilities with intellectual property,
regulatory and licensing insight.
This expertise and experience in the healthcare and pharmaceutical sectors
expedites the development of time and cost effective technologies which aim to
provide:
- a higher standard of clinical care in a variety of disease states by providing better diagnosis and treatment options
- a reduction in cost and lead times in pharmaceutical drug discovery and development.
vivoMedica technologies and devices have applications in established and emergent markets and will enhance the ability to manage disease.
Todays Date:
Current time:
VivoMedica’s DrugPrint could save drug recall casualties
"VivoMedica’s CEO Peter Leyland and Senior Scientist Simon Bryant were recently interviewed by Tina Tan of Clinica for a leading article in January Issue 1288. Peter and Simon discuss the rapid progress in the development of the DrugPrint platform and the successful poster presentation at the SPS meeting (Safety Pharmaceutical Society) that has led to significant interest among both drug and stem cell companies."
>> more infodrugPrint presents at SPS
drugPrintTM presents at Safety Pharmacology Society.....
>> Download pdf fileVivoMedica Plc
Zi Medical (AIM: ZIM), Annual General Meeting all the resolutions were duly passed, including a resolution to change the Company’s name to VivoMedica plc (AIM:VVM)...
>> more info01 Oct - 31 Oct
Breast Cancer Awareness Month
>> Breakthrough Breast Cancer